The new US federal legislation has brought synthetic nicotine products under the oversight of the US Food and Drug Administration (FDA), meaning all synthetic nicotine products have to go through a premarket tobacco product application (PMTA) process. This has led to several questions this report addresses, such as: what the new federal legislation means for synthetic nicotine products; what the concerns were that spurred this legislation; what the next steps will be for synthetic nicotine products; whether there any products that currently do not fit the definition, or whether all products will fall under FDA oversight, and a look into enforcement to see how the market is really going to play out.
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.